Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

BSX Insider Trading

BOSTON SCIENTIFIC CORP | Surgical & Medical Instruments & Apparatus

Comprehensive Trading Performance Summary

The investment history of corporate insiders at BOSTON SCIENTIFIC CORP provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2009-01-15 00:11 2009-01-12 NICHOLAS PETER M Director SELL $7.42 200,000 $1,483,100 17,630,032 -1.1%
2009-01-15 00:11 2009-01-12 ABELE JOHN E Director SELL $7.42 200,000 $1,483,100 31,883,029 -0.6%
2009-01-13 00:40 2009-01-08 NICHOLAS PETER M Director SELL $7.70 200,000 $1,539,600 17,830,032 -1.1%
2009-01-13 00:40 2009-01-08 ABELE JOHN E Director SELL $7.70 200,000 $1,539,600 32,083,029 -0.6%
2009-01-09 00:20 2009-01-06 NICHOLAS PETER M Director SELL $7.91 200,000 $1,582,000 18,030,032 -1.1%
2009-01-09 00:20 2009-01-06 ABELE JOHN E Director SELL $7.91 200,000 $1,582,000 32,283,029 -0.6%
2009-01-07 00:05 2009-01-02 NICHOLAS PETER M Director SELL $7.73 200,000 $1,545,100 18,230,032 -1.1%
2009-01-07 00:05 2009-01-02 ABELE JOHN E Director SELL $7.73 200,000 $1,545,100 32,483,029 -0.6%
2009-01-02 22:44 2008-12-30 NICHOLAS PETER M Director SELL $7.47 200,000 $1,493,800 18,430,032 -1.1%
2009-01-02 22:44 2008-12-30 ABELE JOHN E Director SELL $7.47 200,000 $1,493,800 32,683,029 -0.6%
2008-12-30 21:22 2008-12-26 NICHOLAS PETER M Director SELL $7.35 200,000 $1,470,900 18,630,032 -1.1%
2008-12-30 21:22 2008-12-26 ABELE JOHN E Director SELL $7.35 200,000 $1,470,900 32,883,029 -0.6%
2008-12-24 23:44 2008-12-23 ABELE JOHN E Director SELL $7.43 200,000 $1,486,400 33,083,029 -0.6%
2008-12-24 23:44 2008-12-23 NICHOLAS PETER M Director SELL $7.43 200,000 $1,486,400 18,830,032 -1.1%
2008-12-24 01:05 2008-12-19 NICHOLAS PETER M Director SELL $7.65 200,000 $1,530,900 19,030,032 -1.0%
2008-12-24 01:05 2008-12-19 ABELE JOHN E Director SELL $7.65 200,000 $1,530,900 33,283,029 -0.6%
2008-12-19 20:20 2008-12-17 NICHOLAS PETER M Director SELL $7.82 200,000 $1,563,900 19,230,032 -1.0%
2008-12-19 20:20 2008-12-17 ABELE JOHN E Director SELL $7.82 200,000 $1,563,900 33,483,029 -0.6%
2008-12-18 00:16 2008-12-15 ABELE JOHN E Director SELL $7.24 200,000 $1,447,700 33,683,029 -0.6%
2008-12-18 00:16 2008-12-15 NICHOLAS PETER M Director SELL $7.24 200,000 $1,447,700 19,430,032 -1.0%
2008-12-16 00:06 2008-12-11 NICHOLAS PETER M Director SELL $7.27 200,000 $1,454,700 19,630,032 -1.0%
2008-12-16 00:06 2008-12-11 ABELE JOHN E Director SELL $7.28 200,000 $1,455,000 33,883,029 -0.6%
2008-12-12 00:05 2008-12-09 NICHOLAS PETER M Director SELL $7.31 200,000 $1,461,100 19,830,032 -1.0%
2008-12-10 00:07 2008-12-05 NICHOLAS PETER M Director SELL $7.18 200,000 $1,436,140 20,030,032 -1.0%
2008-12-06 00:06 2008-12-03 NICHOLAS PETER M Director SELL $6.54 312,986 $2,046,240 20,230,032 -1.5%
2008-12-06 00:05 2008-12-03 ABELE JOHN E Director SELL $6.39 27,471 $175,430 34,083,029 -0.1%
2008-12-04 00:15 2008-12-01 NICHOLAS PETER M Director SELL $6.01 1,159,964 $6,972,312 20,508,067 -5.4%
2008-12-04 00:15 2008-12-01 ABELE JOHN E Director SELL $6.01 220,454 $1,324,708 34,110,500 -0.6%
2008-12-02 00:52 2008-11-26 ABELE JOHN E Director SELL $6.10 1,274,000 $7,774,967 34,330,954 -3.6%
2008-12-02 00:52 2008-11-26 NICHOLAS PETER M Director SELL $6.10 2,489,000 $15,184,393 21,401,677 -10.4%
2008-11-26 23:31 2008-11-25 NICHOLAS PETER M Director SELL $6.17 1,021,100 $6,297,022 23,549,677 -4.2%
2008-11-26 23:31 2008-11-25 ABELE JOHN E Director SELL $6.15 198,000 $1,218,096 35,604,954 -0.6%
2008-11-26 00:10 2008-11-21 NICHOLAS PETER M Director SELL $5.78 3,861,700 $22,322,557 24,317,777 -13.7%
2008-11-26 00:09 2008-11-21 ABELE JOHN E Director SELL $5.81 518,500 $3,013,574 35,802,954 -1.4%
2008-11-22 00:11 2008-11-19 NICHOLAS PETER M Director SELL $6.17 2,321,500 $14,312,744 27,447,477 -7.8%
2008-11-22 00:11 2008-11-19 ABELE JOHN E Director SELL $6.25 421,600 $2,634,874 36,321,454 -1.1%
2008-11-22 00:11 2008-11-20 NICHOLAS NJ JR Director BUY $5.60 15,000 $84,000 140,000 +12.0%
2008-11-21 05:31 2008-11-18 NICHOLAS PETER M Director SELL $7.15 100,000 $715,400 29,456,977 -0.3%
2008-11-21 00:09 2008-11-19 NICHOLAS NJ JR Director BUY $6.96 15,000 $104,445 125,000 +13.6%
2008-11-20 00:10 2008-11-17 NICHOLAS PETER M Director SELL $7.31 553,900 $4,047,292 29,556,977 -1.8%
2008-11-20 00:09 2008-11-18 ABELE JOHN E Director SELL $7.26 300,000 $2,177,700 36,743,054 -0.8%
2008-11-20 00:08 2008-11-18 NICHOLAS NJ JR Director BUY $7.34 10,000 $73,400 110,000 +10.0%
2008-11-19 00:04 2008-11-14 NICHOLAS PETER M Director SELL $7.85 4,600 $36,110 30,110,877 0.0%
2008-11-04 00:14 2008-10-30 GROVES RAY J Director BUY $8.75 8,000 $69,992 1,000 +100.0%
2008-10-31 23:14 2008-10-29 NICHOLAS PETER M Director SELL $8.05 60,000 $483,006 30,115,477 -0.2%
2008-10-30 01:35 2008-10-27 NICHOLAS PETER M Director SELL $7.21 4,050,000 $29,185,920 30,175,477 -11.8%
2008-10-29 21:00 2008-10-28 MARIO ERNEST Director BUY $7.40 15,000 $110,936 88,804 +20.3%
2008-10-27 23:18 2008-10-23 NICHOLAS PETER M Director SELL $8.24 1,030,400 $8,489,981 33,325,477 -3.0%
2008-10-27 23:09 2008-10-24 GROVES RAY J Director BUY $8.20 10,000 $82,040 29,167 +52.2%
2008-10-24 23:51 2008-10-22 NICHOLAS PETER M Director SELL $8.66 900,000 $7,794,000 34,355,877 -2.6%
SHOW ENTRIES

How to Interpret $BSX Trades

Not every insider transaction in BOSTON SCIENTIFIC CORP is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $BSX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for BSX

Insider activity data for BOSTON SCIENTIFIC CORP is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $BSX, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.